Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Elizabeth McFarland

Concepts (399)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
53
2026
3210
3.140
Why?
HIV-1
28
2026
911
2.840
Why?
Respiratory Syncytial Virus Vaccines
6
2022
39
2.190
Why?
HIV Antibodies
14
2026
61
2.190
Why?
Respiratory Syncytial Virus Infections
6
2022
139
2.000
Why?
Respiratory Syncytial Virus, Human
6
2022
81
1.990
Why?
Infectious Disease Transmission, Vertical
18
2025
188
1.970
Why?
Anti-HIV Agents
15
2026
914
1.690
Why?
Anti-Retroviral Agents
12
2023
250
1.620
Why?
Viral Proteins
3
2020
350
1.470
Why?
Antibodies, Neutralizing
10
2026
346
1.100
Why?
Antibodies, Viral
8
2022
683
1.050
Why?
Antibodies, Monoclonal
7
2026
1511
0.940
Why?
Colonography, Computed Tomographic
3
2024
8
0.910
Why?
Pregnancy Complications, Infectious
9
2026
437
0.870
Why?
HIV Protease Inhibitors
3
2026
69
0.810
Why?
AIDS Vaccines
8
2018
53
0.800
Why?
Pre-Exposure Prophylaxis
1
2025
272
0.710
Why?
Gene Deletion
2
2020
384
0.690
Why?
Breast Feeding
4
2025
447
0.610
Why?
Atazanavir Sulfate
2
2017
41
0.600
Why?
Ritonavir
2
2017
75
0.580
Why?
Infant, Newborn
24
2026
6449
0.550
Why?
HIV Envelope Protein gp120
6
2017
55
0.540
Why?
Vaccination
6
2020
1444
0.540
Why?
Vaccines, Attenuated
6
2022
129
0.540
Why?
Infant
34
2026
10093
0.530
Why?
Incidental Findings
1
2018
81
0.510
Why?
Radiation Dosage
1
2018
193
0.480
Why?
Nelfinavir
1
2016
7
0.480
Why?
Telemedicine
1
2025
956
0.470
Why?
Lopinavir
1
2016
30
0.470
Why?
Syncope
1
2016
48
0.470
Why?
Patient Dropouts
1
2016
65
0.460
Why?
Bradycardia
1
2016
63
0.460
Why?
Lyme Disease
1
2016
58
0.450
Why?
Health Resources
1
2016
130
0.430
Why?
Infant, Newborn, Diseases
1
2016
113
0.420
Why?
HIV
5
2014
249
0.390
Why?
Child
40
2026
22638
0.390
Why?
Humans
80
2026
145625
0.390
Why?
Patient Compliance
2
2018
587
0.370
Why?
Female
54
2026
79080
0.370
Why?
Immunogenicity, Vaccine
4
2021
40
0.350
Why?
Adolescent
30
2026
22451
0.340
Why?
Male
45
2026
73014
0.340
Why?
Referral and Consultation
1
2018
878
0.340
Why?
T-Lymphocytes, Cytotoxic
4
2005
180
0.330
Why?
CD4-Positive T-Lymphocytes
2
2017
1148
0.330
Why?
Virus Replication
4
2020
525
0.330
Why?
Viral Load
10
2026
525
0.310
Why?
Lymphocyte Activation
5
2017
1136
0.300
Why?
Young Adult
15
2026
14240
0.290
Why?
DNA, Viral
3
2026
352
0.260
Why?
HIV Seropositivity
2
2023
117
0.260
Why?
Bone Density
2
2025
492
0.260
Why?
Double-Blind Method
3
2020
2064
0.240
Why?
RNA, Viral
8
2023
691
0.230
Why?
Antibodies, Bacterial
2
2018
147
0.230
Why?
Child, Preschool
23
2026
11888
0.220
Why?
Antiretroviral Therapy, Highly Active
6
2017
278
0.220
Why?
Dyslipidemias
2
2017
184
0.220
Why?
Bone Development
1
2025
52
0.220
Why?
Prenatal Exposure Delayed Effects
2
2026
662
0.220
Why?
Puberty
1
2026
141
0.210
Why?
Immunoenzyme Techniques
1
2005
196
0.210
Why?
Pregnancy
12
2026
7217
0.210
Why?
Immunoglobulin G
3
2022
899
0.210
Why?
Viremia
3
2011
158
0.200
Why?
Diverticulum
1
2024
14
0.200
Why?
Gene Products, gag
2
1994
38
0.200
Why?
Mammography
1
2025
172
0.190
Why?
Squalene
3
2017
9
0.190
Why?
Complementarity Determining Regions
1
2002
54
0.180
Why?
Prospective Studies
5
2025
8087
0.180
Why?
Drug Resistance, Viral
2
2016
126
0.180
Why?
CD4 Lymphocyte Count
4
2017
280
0.170
Why?
Half-Life
1
2021
157
0.170
Why?
Growth Differentiation Factor 15
1
2021
44
0.170
Why?
Immunization Schedule
2
2018
186
0.170
Why?
Feasibility Studies
1
2025
1125
0.170
Why?
Mitochondrial Diseases
1
2021
94
0.160
Why?
Colorado
4
2025
4588
0.160
Why?
Drug Therapy, Combination
4
2017
1034
0.160
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
330
0.160
Why?
T-Lymphocytes
2
2009
2007
0.160
Why?
Fibroblast Growth Factors
1
2021
187
0.160
Why?
RNA, Small Untranslated
1
2020
14
0.160
Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
15
0.150
Why?
Pilot Projects
1
2025
1878
0.150
Why?
Hydrophobic and Hydrophilic Interactions
1
2020
193
0.150
Why?
Cytokines
2
2021
2079
0.150
Why?
Point Mutation
1
2020
232
0.140
Why?
Body Temperature
1
2020
227
0.140
Why?
Immunocompromised Host
2
2000
201
0.140
Why?
Haemophilus Vaccines
2
2018
29
0.140
Why?
Insulin Resistance
3
2019
1247
0.140
Why?
Immunologic Memory
2
2021
369
0.140
Why?
Interleukin-12
1
1998
115
0.130
Why?
Adult
18
2026
40821
0.130
Why?
Darunavir
1
2017
20
0.130
Why?
Mycobacterium Infections, Nontuberculous
2
2012
339
0.130
Why?
CD8-Positive T-Lymphocytes
2
2011
929
0.130
Why?
Metabolic Syndrome
1
2021
364
0.130
Why?
Vinyl Chloride
1
2017
2
0.130
Why?
Dose-Response Relationship, Drug
1
2021
2018
0.130
Why?
Therapeutic Equipoise
1
2017
1
0.130
Why?
Interferon-gamma
5
2012
780
0.130
Why?
Antibody Formation
1
2018
290
0.120
Why?
Immunoglobulin A
2
2017
205
0.120
Why?
Lymphopoiesis
1
2017
27
0.120
Why?
Uganda
1
2017
91
0.120
Why?
Receptors, CCR5
1
2017
59
0.120
Why?
CD4-CD8 Ratio
1
2016
23
0.120
Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
9
0.120
Why?
Mass Casualty Incidents
1
2017
52
0.120
Why?
High-Throughput Screening Assays
1
2018
179
0.120
Why?
Adoption
1
2016
25
0.120
Why?
Mothers
3
2017
771
0.120
Why?
Virus Latency
1
2016
93
0.110
Why?
Cohort Studies
8
2025
6045
0.110
Why?
Early Diagnosis
1
2016
249
0.110
Why?
Chickenpox Vaccine
1
2015
75
0.110
Why?
Continuity of Patient Care
1
2018
297
0.110
Why?
Disease Susceptibility
1
2017
339
0.110
Why?
Zimbabwe
2
2025
76
0.110
Why?
Body Height
2
2017
202
0.110
Why?
Gene Products, env
1
1994
7
0.110
Why?
Haemophilus influenzae type b
1
2014
12
0.110
Why?
Chickenpox
1
2015
83
0.110
Why?
Bacterial Capsules
1
2014
33
0.110
Why?
Antibody Affinity
1
2014
60
0.110
Why?
Acquired Immunodeficiency Syndrome
2
2000
237
0.100
Why?
Cote d'Ivoire
2
2025
9
0.100
Why?
Parotitis
1
2014
6
0.100
Why?
Vaccines, Synthetic
4
2005
138
0.100
Why?
Developing Countries
1
2016
312
0.100
Why?
South Africa
2
2025
262
0.100
Why?
Intestines
1
2017
351
0.100
Why?
Puberty, Delayed
1
2013
10
0.100
Why?
Cytotoxicity, Immunologic
3
2002
224
0.100
Why?
Leukocytes, Mononuclear
4
2013
585
0.100
Why?
Vaccines
1
2018
389
0.100
Why?
RNA-Directed DNA Polymerase
1
1993
34
0.100
Why?
Mycobacterium chelonae
1
1993
8
0.100
Why?
Injections, Subcutaneous
2
2026
170
0.100
Why?
United States
10
2026
16041
0.090
Why?
Patient Selection
1
2017
720
0.090
Why?
Lamivudine
3
2023
63
0.090
Why?
Retrospective Studies
8
2023
17291
0.090
Why?
Lipids
1
2017
715
0.090
Why?
Cell Movement
1
2017
950
0.090
Why?
Colorectal Neoplasms
1
2020
870
0.090
Why?
Child Development
1
2017
481
0.090
Why?
Mitochondria
2
2021
996
0.090
Why?
Breast Neoplasms
1
2025
2411
0.090
Why?
STAT1 Transcription Factor
1
2012
68
0.090
Why?
Body Weight
2
2017
964
0.090
Why?
Cardiovascular Diseases
2
2016
2218
0.090
Why?
Pediatric Obesity
1
2019
635
0.090
Why?
Body Fat Distribution
1
2011
46
0.090
Why?
Polysorbates
3
2017
42
0.090
Why?
Clinical Trials as Topic
1
2017
1062
0.090
Why?
Mycobacterium avium Complex
1
2012
87
0.080
Why?
Epitopes
2
2022
479
0.080
Why?
Cost-Benefit Analysis
2
2025
632
0.080
Why?
Research Design
1
2017
1139
0.080
Why?
Biomedical Research
1
2017
724
0.080
Why?
Interleukin-2
2
2003
434
0.080
Why?
Emergency Medical Services
1
2017
680
0.080
Why?
Respiratory Tract Infections
1
2014
399
0.070
Why?
Freezing
1
2009
84
0.070
Why?
Absorptiometry, Photon
2
2025
276
0.070
Why?
Exercise
1
2021
2206
0.070
Why?
Blood
1
2009
107
0.070
Why?
Phenotype
1
2017
3186
0.070
Why?
Algorithms
1
2016
1843
0.070
Why?
Age Factors
4
2019
3321
0.070
Why?
T-Lymphocyte Subsets
2
2002
415
0.070
Why?
Staff Development
1
2009
62
0.070
Why?
Lymphocyte Subsets
2
2009
79
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2021
845
0.070
Why?
Biomarkers
4
2021
4329
0.070
Why?
Specimen Handling
1
2009
178
0.060
Why?
Enterovirus A, Human
1
2007
13
0.060
Why?
Longitudinal Studies
3
2025
3005
0.060
Why?
Faculty
1
2009
151
0.060
Why?
Withholding Treatment
1
2008
77
0.060
Why?
Adipose Tissue
1
2011
641
0.060
Why?
Central Nervous System Viral Diseases
1
2007
78
0.060
Why?
Polymerase Chain Reaction
4
2011
1030
0.060
Why?
Puerto Rico
1
2026
64
0.060
Why?
Flow Cytometry
3
2009
1160
0.060
Why?
Monte Carlo Method
1
2026
150
0.060
Why?
Academic Medical Centers
1
2009
560
0.060
Why?
False Negative Reactions
1
2025
61
0.050
Why?
Cell Line
3
2012
2809
0.050
Why?
Enterovirus Infections
1
2007
175
0.050
Why?
Isoantigens
1
1984
17
0.050
Why?
C-Reactive Protein
2
2021
427
0.050
Why?
Medical Audit
1
2025
77
0.050
Why?
Immunity, Cellular
1
2006
277
0.050
Why?
Linear Models
2
2020
847
0.050
Why?
Disease Outbreaks
1
2007
420
0.050
Why?
Sequence Analysis, DNA
2
2007
771
0.050
Why?
Follow-Up Studies
3
2021
5397
0.050
Why?
Confusion
1
2024
30
0.050
Why?
Comorbidity
2
2021
1652
0.050
Why?
Thymus Gland
1
1984
310
0.050
Why?
Hospitalization
2
2026
2468
0.050
Why?
Tablets
1
2023
41
0.050
Why?
Constriction, Pathologic
1
2024
238
0.050
Why?
Regression Analysis
2
2021
994
0.050
Why?
Respiratory Syncytial Viruses
1
2022
58
0.050
Why?
Genes, T-Cell Receptor beta
1
2002
22
0.050
Why?
Risk Factors
4
2021
10840
0.050
Why?
Immunophenotyping
2
1994
324
0.050
Why?
Zidovudine
2
2015
75
0.050
Why?
Clone Cells
1
2002
259
0.040
Why?
Dose-Response Relationship, Immunologic
1
2001
77
0.040
Why?
Cough
1
2022
123
0.040
Why?
Emtricitabine
1
2023
209
0.040
Why?
Triazoles
1
2023
190
0.040
Why?
Vaccines, Subunit
1
2001
53
0.040
Why?
Clinical Trials, Phase I as Topic
1
2021
49
0.040
Why?
Pyridones
1
2023
210
0.040
Why?
Ganciclovir
1
2000
51
0.040
Why?
Tenofovir
1
2023
300
0.040
Why?
Public Health Surveillance
1
2021
84
0.040
Why?
Lung
1
2014
4119
0.040
Why?
Computer Simulation
1
2005
1014
0.040
Why?
Africa
1
2020
119
0.040
Why?
Adjuvants, Immunologic
2
2017
243
0.040
Why?
Diagnostic Tests, Routine
1
2021
108
0.040
Why?
Symptom Assessment
1
2021
137
0.040
Why?
Sex Factors
2
2019
2101
0.040
Why?
HIV Seronegativity
1
2019
28
0.040
Why?
Cross-Sectional Studies
3
2021
5875
0.040
Why?
HLA-D Antigens
1
1999
30
0.040
Why?
Risk
1
2021
917
0.040
Why?
Incidence
1
2026
2910
0.040
Why?
Case-Control Studies
2
2019
3633
0.040
Why?
Lymphocyte Culture Test, Mixed
1
1998
49
0.030
Why?
Cytomegalovirus Infections
1
2000
203
0.030
Why?
Cytotoxicity Tests, Immunologic
1
1998
39
0.030
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
28
0.030
Why?
Vaccines, Combined
1
2018
49
0.030
Why?
Prevalence
2
2016
2852
0.030
Why?
Cholesterol, HDL
1
2019
201
0.030
Why?
Amino Acid Sequence
1
2002
2088
0.030
Why?
Hospitals
1
2023
730
0.030
Why?
Poliovirus Vaccine, Inactivated
1
2018
27
0.030
Why?
Odds Ratio
1
2021
1070
0.030
Why?
Hepatitis B Vaccines
1
2018
43
0.030
Why?
Mutation
3
2018
4082
0.030
Why?
Molecular Sequence Data
1
2002
2835
0.030
Why?
Drug Resistance, Microbial
2
2000
67
0.030
Why?
Nutrition Surveys
1
2019
270
0.030
Why?
Colon
1
2020
304
0.030
Why?
Case Management
1
2018
66
0.030
Why?
Antigens, Viral
1
1998
186
0.030
Why?
Cholesterol, LDL
1
2019
363
0.030
Why?
New Jersey
1
2017
17
0.030
Why?
Cholesterol
1
2019
410
0.030
Why?
Epitopes, T-Lymphocyte
1
1998
175
0.030
Why?
Treatment Adherence and Compliance
1
2017
27
0.030
Why?
Immune Tolerance
1
1999
384
0.030
Why?
Triglycerides
1
2019
527
0.030
Why?
Disease Management
1
2021
649
0.030
Why?
Reproducibility of Results
1
2005
3396
0.030
Why?
Cell Division
1
1998
735
0.030
Why?
Emergency Responders
1
2017
38
0.030
Why?
Lymphocyte Count
2
2009
166
0.030
Why?
Middle Aged
4
2026
36359
0.030
Why?
Treatment Failure
1
2017
358
0.030
Why?
Uncertainty
1
2017
145
0.030
Why?
Disaster Planning
1
2017
109
0.030
Why?
Nevirapine
1
2015
17
0.030
Why?
Seroepidemiologic Studies
1
2015
169
0.030
Why?
Multicenter Studies as Topic
1
2017
413
0.030
Why?
Patient Outcome Assessment
1
2016
128
0.030
Why?
Maternal Exposure
1
2017
189
0.030
Why?
Genes, pol
1
1994
7
0.030
Why?
Malnutrition
1
2016
86
0.030
Why?
Vaccines, Conjugate
1
2014
60
0.030
Why?
Antiviral Agents
1
2000
774
0.030
Why?
Coinfection
1
2016
143
0.030
Why?
Counseling
1
2018
403
0.030
Why?
Neutropenia
1
2015
153
0.030
Why?
Time-to-Treatment
1
2017
257
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1754
0.030
Why?
Treatment Outcome
2
2021
11744
0.030
Why?
Cells, Cultured
2
2008
4112
0.030
Why?
Global Health
1
2017
402
0.020
Why?
Anemia
1
2015
189
0.020
Why?
Maternal-Fetal Exchange
1
2014
171
0.020
Why?
Electron Transport Complex IV
1
2013
61
0.020
Why?
Electron Transport Complex I
1
2013
42
0.020
Why?
Sexual and Gender Minorities
1
2018
268
0.020
Why?
Thrombocytopenia
1
2015
205
0.020
Why?
Tuberculosis, Cutaneous
1
1993
2
0.020
Why?
HIV Reverse Transcriptase
1
1993
32
0.020
Why?
CD8 Antigens
1
1993
70
0.020
Why?
Radiography, Thoracic
1
2014
174
0.020
Why?
Severity of Illness Index
1
2021
2910
0.020
Why?
Medication Adherence
1
2017
535
0.020
Why?
Drug Administration Schedule
2
2008
782
0.020
Why?
CD3 Complex
1
1993
112
0.020
Why?
Lymphocytes
1
1994
379
0.020
Why?
Blood Pressure
1
2019
1761
0.020
Why?
Oxidative Phosphorylation
1
2013
212
0.020
Why?
DNA, Mitochondrial
1
2013
212
0.020
Why?
P-Selectin
1
2011
29
0.020
Why?
Tuberculosis, Pulmonary
1
1993
127
0.020
Why?
E-Selectin
1
2011
61
0.020
Why?
Heteroduplex Analysis
1
2011
1
0.020
Why?
Pandemics
1
2020
1700
0.020
Why?
Chemokine CCL2
1
2011
112
0.020
Why?
Blood Transfusion
1
1994
393
0.020
Why?
Antigens, CD
1
1994
559
0.020
Why?
Cell Proliferation
2
2009
2497
0.020
Why?
Nontuberculous Mycobacteria
1
1993
189
0.020
Why?
Hyperlipidemias
1
2011
120
0.020
Why?
Protein Multimerization
1
2012
201
0.020
Why?
Interferon-alpha
1
2012
201
0.020
Why?
Cell Adhesion Molecules
1
2011
180
0.020
Why?
Fibrinogen
1
2011
181
0.020
Why?
Communication
1
2017
979
0.020
Why?
Health Personnel
1
2017
750
0.020
Why?
Cross Infection
1
1993
258
0.020
Why?
Healthcare Disparities
1
2017
728
0.020
Why?
Infant, Premature
1
1994
622
0.020
Why?
Diagnosis, Differential
1
2014
1500
0.020
Why?
Pokeweed Mitogens
1
2009
6
0.020
Why?
Human Experimentation
1
2009
12
0.020
Why?
L-Selectin
1
2009
27
0.020
Why?
Tetanus
1
2009
29
0.020
Why?
Leukocyte Common Antigens
1
2009
86
0.020
Why?
Candida
1
2009
46
0.020
Why?
Multivariate Analysis
1
2011
1531
0.020
Why?
Meningitis, Aseptic
1
2007
13
0.020
Why?
Obesity
1
2021
3123
0.020
Why?
Virus Cultivation
1
2007
31
0.020
Why?
Phosphorylation
1
2012
1717
0.020
Why?
Interleukin-6
1
2011
782
0.020
Why?
Data Interpretation, Statistical
1
2009
365
0.020
Why?
Cerebrospinal Fluid
1
2007
88
0.020
Why?
Paralysis
1
2007
69
0.020
Why?
Multiple Organ Failure
1
2007
122
0.020
Why?
Kinetics
1
2010
1553
0.010
Why?
B-Lymphocytes
1
2012
884
0.010
Why?
Pregnancy Outcome
1
2010
502
0.010
Why?
Respiratory System
1
2007
150
0.010
Why?
Genotype
1
2011
1866
0.010
Why?
Immunoglobulin A, Secretory
1
2005
8
0.010
Why?
Cell Survival
1
2009
1102
0.010
Why?
Phosphates
1
1987
175
0.010
Why?
Muscles
1
1987
330
0.010
Why?
Encephalitis
1
2007
142
0.010
Why?
Gastrointestinal Tract
1
2007
203
0.010
Why?
Mucous Membrane
1
2005
129
0.010
Why?
Chemistry, Physical
1
1984
36
0.010
Why?
Antigen-Antibody Reactions
1
1984
50
0.010
Why?
Chemical Phenomena
1
1984
75
0.010
Why?
Emergency Service, Hospital
1
2017
2357
0.010
Why?
DNA-Binding Proteins
1
2012
1467
0.010
Why?
Myasthenia Gravis
1
1984
24
0.010
Why?
Immunologic Deficiency Syndromes
1
1984
69
0.010
Why?
Tissue Distribution
1
1984
334
0.010
Why?
Saliva
1
2005
256
0.010
Why?
Epithelium
1
1984
295
0.010
Why?
Tomography, X-Ray Computed
1
2014
2766
0.010
Why?
Aging
2
2003
1983
0.010
Why?
Blood Glucose
1
2013
2357
0.010
Why?
Body Mass Index
1
2011
2446
0.010
Why?
Infusions, Intravenous
1
2003
429
0.010
Why?
Reference Values
1
2003
787
0.010
Why?
Anti-Bacterial Agents
1
1993
1935
0.010
Why?
Aged
2
2017
26251
0.010
Why?
Mice, Inbred BALB C
1
1984
1244
0.010
Why?
Suspensions
1
2000
28
0.010
Why?
Capsules
1
2000
40
0.010
Why?
Drug Tolerance
1
2000
99
0.010
Why?
Urban Population
1
2003
496
0.010
Why?
Cytomegalovirus
1
2000
169
0.010
Why?
Signal Transduction
1
2012
5234
0.010
Why?
Immunization
1
2000
375
0.010
Why?
Epithelial Cells
1
1984
1118
0.010
Why?
Administration, Oral
1
2000
867
0.010
Why?
Time Factors
1
2008
7079
0.010
Why?
Recombinant Proteins
1
2000
1361
0.010
Why?
Macrophages
1
1984
1530
0.010
Why?
Tail
1
1987
28
0.000
Why?
Phosphocreatine
1
1987
44
0.000
Why?
Mice
1
1984
18266
0.000
Why?
Salamandridae
1
1987
33
0.000
Why?
Animals
2
1987
38030
0.000
Why?
Adenosine Triphosphate
1
1987
494
0.000
Why?
Magnetic Resonance Spectroscopy
1
1987
627
0.000
Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)